CorMedix Inc. SEC filings CRMD
CorMedix Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Sep 24, 2012. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 POS | Filing | Jun 25, 2026 | — |
| S-8 | Employee stock plan registration | Nov 13, 2025 | — |
| S-3ASR | Automatic shelf registration | Oct 7, 2025 | — |
| S-3ASR | Automatic shelf registration | Oct 6, 2025 | — |
| S-3 | Shelf registration | Sep 30, 2025 | — |
| 424B5 | Prospectus supplement | Jun 30, 2025 | — |
| 424B5 | Prospectus supplement | Jun 26, 2025 | — |
| S-3 | Shelf registration | May 9, 2024 | — |
| 424B5 | Prospectus supplement | Jun 30, 2023 | — |
| 424B5 | Prospectus supplement | Jun 28, 2023 | — |
| S-8 | Employee stock plan registration | Oct 26, 2022 | — |
| 424B5 | Prospectus supplement | Aug 12, 2021 | — |
| S-3 | Shelf registration | Aug 12, 2021 | — |
| 424B5 | Prospectus supplement | Feb 5, 2021 | — |
| 424B5 | Prospectus supplement | Nov 27, 2020 | — |
| S-3 | Shelf registration | Nov 5, 2020 | — |
| 424B5 | Prospectus supplement | Aug 31, 2020 | — |
| 424B5 | Prospectus supplement | Jul 29, 2020 | — |
| 424B5 | Prospectus supplement | Jul 27, 2020 | — |
| S-8 | Employee stock plan registration | Dec 17, 2019 | — |
| 424B5 | Prospectus supplement | Sep 25, 2019 | — |
| 424B5 | Prospectus supplement | Nov 15, 2018 | — |
| 424B3 | Prospectus | Oct 23, 2018 | — |
| S-3 | Shelf registration | Oct 15, 2018 | — |
| 424B3 | Prospectus | Apr 17, 2018 | — |
| S-3/A | Amendment no 1 | Apr 11, 2018 | — |
| S-3 | Shelf registration | Mar 9, 2018 | — |
| 424B5 | Prospectus supplement | Dec 8, 2017 | — |
| 424B5 | Prospectus supplement | Nov 20, 2017 | — |
| 424B5 | Prospectus supplement | Apr 28, 2017 | — |
| FWP | Free writing prospectus | Apr 28, 2017 | — |
| FWP | Free writing prospectus | Apr 27, 2017 | — |
| 424B5 | Prospectus supplement | Apr 27, 2017 | — |
| S-3/A | Amendment no. 1 to form s-3 | Oct 13, 2016 | — |
| S-3 | Shelf registration | Aug 26, 2016 | — |
| S-8 | Employee stock plan registration | Jul 7, 2016 | — |
| 424B3 | Prospectus | Jun 9, 2016 | — |
| POS AM | Filing | May 31, 2016 | — |
| POS AM | Filing | May 31, 2016 | — |
| POS AM | Registration statement | May 31, 2016 | — |
| S-3 | Shelf registration | May 27, 2016 | — |
| 424B3 | Prospectus | Apr 21, 2015 | — |
| S-3 | Shelf registration | Apr 9, 2015 | — |
| 424B1 | Filing | Mar 20, 2015 | — |
| 424B1 | Filing | Mar 20, 2015 | — |
| POS AM | Filing | Mar 13, 2015 | — |
| S-3 | Shelf registration | Mar 13, 2015 | — |
| 424B3 | Prospectus | Mar 9, 2015 | — |
| 424B3 | Prospectus | Mar 4, 2015 | — |
| 424B4 | Prospectus | Feb 17, 2015 | — |
| POS AM | Registration statement | Feb 5, 2015 | — |
| 424B5 | Prospectus supplement | Mar 6, 2014 | — |
| S-8 | Employee stock plan registration | Dec 13, 2013 | — |
| 424B5 | Prospectus supplement | Oct 21, 2013 | — |
| 424B5 | Prospectus supplement | Jul 26, 2013 | — |
| 424B5 | Prospectus supplement | May 24, 2013 | — |
| 424B3 | Prospectus | Apr 4, 2013 | — |
| S-3/A | Form s-3/a | Mar 28, 2013 | — |
| S-3/A | Form s-3/a | Feb 22, 2013 | — |
| 424B5 | Prospectus supplement | Feb 19, 2013 | — |
| S-3 | Shelf registration | Jan 11, 2013 | — |
| S-3/A | Amendment to form s-3 | Jan 9, 2013 | — |
| S-3 | Shelf registration | Dec 28, 2012 | — |
Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CRMD (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Parsippany, NJ
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1410098
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.